vancomycin has been researched along with Community Acquired Infection in 146 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (8.90) | 18.2507 |
| 2000's | 64 (43.84) | 29.6817 |
| 2010's | 58 (39.73) | 24.3611 |
| 2020's | 11 (7.53) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Danese, P; DeVito, J; Franceschi, F; Lawrence, L; Sutcliffe, J | 1 |
| Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
| Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
| Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Watanabe, Y | 1 |
| Brateanu, A; Imrey, PB; Le, P; Navaneethan, SD; Pallotta, AM; Patel, P; Rastogi, R; Rothberg, MB; Yu, PC | 1 |
| Chen, W; Liu, J; Liu, Q; Lu, G; Shen, Q; Wang, C; Wang, Y; Xiao, P; Yan, G; Yang, X | 1 |
| Abate, G; Frisby, J; Wang, G | 1 |
| Hayashi, T; Katayama, M; Komori, K; Mori, N; Sugiura, T; Yamaguchi, T | 1 |
| Habib, A; Qadir, A | 1 |
| Genies, M; Gourishankar, A; Johnson, DP; Lee, V; Rajbhandari, P; Schefft, M | 1 |
| Li, F; Sun, L; Wang, X; Wang, Y | 1 |
| Dalponte, RS; Heluany, GCV; Madeira, K; Michels, M; Prado, CE | 1 |
| Abdul Latif, M; Krishnasamy, G; Vallavan, V; Zin, NM | 1 |
| Adelman, MW; Fridkin, SK; Goodenough, D; Mackey, C; Sefton, S; Thomas, S; Woodworth, MH | 1 |
| Buckingham, DA; Diaz, A; Gallup, N; Hecht, SM; Karsies, T; Katragkou, A; Lanata, MM; Sargel, C; Tansmore, JL; Watson, JR | 1 |
| Bryan, M; Gerber, JS; Hamdy, RF; Hersh, AL; Hsu, AJ; Olson, JA; Stockmann, C; Tamma, PD | 1 |
| Baek, JY; Chung, DR; Kang, CI; Kim, SH; Ko, KS; Peck, KR; Song, JH; Yang, SJ | 1 |
| Fasihi, Y; Kalantar-Neyestanaki, D; Kiaei, S | 1 |
| Gould, IM; Khan, A; Wilson, B | 1 |
| Cammarata, S; Cruz-Saldariagga, M; Lawrence, L; Liang, S; McManus, A; O'Riordan, W; Poromanski, I; Quintas, M; Teras, J | 1 |
| Arbogast, ZQ; Dunaway, S; Giancola, SE; Myers, ZL; Orwig, KW; Sizemore, JA | 1 |
| Kolakshyapati, M; Li, M; Lou, L; Shi, LF; Shrestha, T; Wang, Z; Yang, KC; Zhou, J | 1 |
| Kalyanaraman, M; Morparia, K; Peshkovsky, C | 1 |
| Cai, Y; Wang, H; Wang, J; Zhang, K; Zhang, L; Zhou, L | 1 |
| Buckel, W; Dean, NC; Jephson, A; Mecham, I; Ooi, L; Sorensen, J; Webb, BJ | 1 |
| Liu, Y; Shen, P; Song, J; Wang, Y; Xiao, Y; Zhou, K; Zhou, Y | 1 |
| Alvarez, AM; Rathore, MH | 1 |
| Bosco, JA; Hadley, S; Hutzler, L; Mehta, S; Phillips, M; Slover, J | 1 |
| Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
| Keynan, Y; Rubinstein, E | 1 |
| Baek, JY; Chung, DR; Kang, CI; Kim, SH; Ko, J; Lee, NY; Park, SY; Peck, KR; Song, JH | 1 |
| Cattoir, V; Dargère, S; Daurel, C; Fines-Guyon, M; Margat, E; Michon, J; Verdon, R | 1 |
| Kawaguchi, T; Kurahara, Y | 1 |
| Cioara, A; Filipescu, I; Flonta, M; Lupse, M; Todor, N | 1 |
| Araki, K; Goto, H; Kikuchi, K; Koide, T; Makino, H; Ogawa, Y; Ohkuma, K; Saraya, T; Takizawa, H; Yonetani, S | 1 |
| Hatef, DA; Janis, JE; Reece, EM; Wong, C | 1 |
| Avila-Morales, J; Garcia-G, MC; Leo-Amador, GE; Sanchez-Corona, J; Zaldívar-Lelo de Larrea, G | 1 |
| Chang, CH; Chang, SC; Chen, SC; Chen, SY; Chen, WJ; Chiang, WC; Chie, WC; Hsueh, PR; Huang, EP; Lai, MS; Lin, CF | 1 |
| Alavi Darazam, I; Shokouhi, S | 1 |
| Chen, CM; Chen, WY; Chen, YH; Chen, YS; Cheng, YJ; Chiang, PC; Chuang, YC; Hsu, GJ; Hsueh, PR; Huang, CH; Jang, TN; Ko, WC; Kung, HC; Lee, CM; Lee, MH; Liao, CH; Lin, HC; Liu, CE; Liu, CY; Liu, JW; Liu, YC; Lu, CT; Lu, PL; Pan, SC; Shi, ZY; Sun, W; Thomas, CY; Tsao, SM; Wang, LS; Wang, WY; Yang, JL; Yu, KW | 1 |
| Chung, DR; Huh, K | 1 |
| Chen, SJ; Chou, YL; Hsieh, KH; Lo, WT; Wang, CC | 1 |
| Balbuena Segura, AI; Corrales Fernández, MJ; Gea Velázquez de Castro, MT | 1 |
| Blumer, JL; Bradley, JS; Cannavino, C; Friedland, HD; Ghonghadze, T; Jandourek, A; O'Neal, T | 1 |
| Changchien, CH; Chen, SW; Chen, YY; Chu, C | 1 |
| Adler, A; Carmeli, Y; Cohen, D; Miller-Roll, T; Na'amnih, W | 1 |
| Manaloor, JJ; Patel, PR; Scheffer, AL | 1 |
| Kaysin, A; Viera, AJ | 1 |
| Baro, E; Denies, F; Dervaux, B; Galperine, T; Guery, B; Lannoy, D; Lenne, X; Odou, P | 1 |
| Dickson, RP; Martinez, SM; Ortiz, JR | 1 |
| Chang, CC; Chen, CL; Hsieh, YY; Tsai, HD | 1 |
| Decker, CF; Johnson, MD | 1 |
| Beeston, CJ; Chadwick, PR; Gupta, R; Young, RJ | 1 |
| Bayer, AS; Cheung, AL; Memmi, G; Trotonda, MP; Xiong, YQ | 1 |
| Cercenado, E; Ruiz de Gopegui, E | 1 |
| Hammerman, WA; Hulten, KG; Kaplan, SL; Lamberth, LB; Mason, EO; Versalovic, J | 1 |
| Hoban, DJ; Karlowsky, JA; Nichol, K; Noreddin, AM; Voth, D; Zhanel, GG | 1 |
| Ko, MG; Maffi, BJ; Marzolf, SM | 1 |
| Aldag, JC; Gray, BM; Mankin, P; Mongkolrattanothai, K | 1 |
| Baraboutis, IG; Belesiotou, H; Kontogianni-Katsarou, K; Kontothanasis, D; Koukoulaki, M; Paniara, O; Papastamopoulos, V; Platsouka, E; Skoutelis, AT; Tsagalou, EP | 1 |
| Bilal, M; Cleveland, KO; Gelfand, MS | 1 |
| Schlaudecker, JD | 1 |
| Caird, MS; Farley, FA; Hensinger, RN; Karmazyn, B; Lubicky, JP; Vander Have, KL; Verma, M | 1 |
| Creech, CB; Jimenez-Truque, N; Saye, E; Thomsen, I | 1 |
| Boyeras Navarro, ID; Luna, CM | 1 |
| Amir, J; Bilavsky, E; Dagan, R; Keller, N; Porat, N; Shouval, DS; Sivan, Y | 1 |
| Chang, HH; Cheong, HS; Chung, DR; Heo, ST; Joung, MK; Jung, DS; Jung, SI; Ki, HK; Kim, SW; Kim, YS; Kwon, KT; Lee, H; Lee, JA; Lee, JS; Lee, SS; Moon, C; Moon, SY; Peck, KR; Rhee, JY; Ryu, SY; Shin, SY; Son, JS; Song, JH | 1 |
| Cleary, TG; Contreras, GA; Heresi, GP; Murphy, JR; Pérez, N | 1 |
| Gonzalez, F; Li, X; Mu, D; Tang, J; Wang, H; Xiong, Y | 1 |
| Hewett, ML | 1 |
| Barriere, SL; Benton, BM; Kitt, MM; Krause, KM | 1 |
| Baorto, E; Barisciano, L; Davis, J; Horowitz, IN | 1 |
| Cattoir, V; Leclercq, R | 1 |
| Cercenado, E | 1 |
| Dresser, LD; MacLean, RD; McGavin, MJ; Simor, AE; Tsuji, BT | 1 |
| Beekmann, SE; Hersh, AL; Newland, JG; Polgreen, PM; Shah, SS; Shapiro, DJ | 1 |
| Lemonovich, TL; Watkins, RR | 1 |
| Gole, GA; Grimwood, K; Nimmo, GR; Nissen, MD; Paterson, DL; Vaska, VL | 1 |
| Badiou, C; Couet, W; Lina, G; Pantrangi, M; Pichereau, S; Rose, WE; Shukla, SK | 1 |
| Hautala, T; Koskela, M; Luttinen, S; Rahkonen, M | 1 |
| Cambon, A; Kong, M; Smith, MJ; Woods, CR | 1 |
| Chu, YC; Huang, YC; Lee, CY; Lei, TH; Lien, R | 1 |
| Chang, SC; Chen, SY; Chen, WJ; Chiang, WC; Chie, WC; Hsueh, PR; Lai, MS; Liao, CH; Wang, JL | 1 |
| Giuliano, C; Johnson, LB; Kale-Pradhan, PB | 1 |
| Arnold, FW; Griffin, AT; Peyrani, P; Ramirez, JA; Wiemken, TL | 1 |
| Huang, YC; Lai, JY; Lee, WJ; Lien, R; Lim, WH | 1 |
| Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI | 1 |
| Moran, GJ; Mount, J | 1 |
| Al-Doori, Z | 1 |
| Clark, NM; Hershberger, E; Lynch, JP; Zervosc, MJ | 1 |
| Karpov, OI; Sidorenko, SV; Zaĭtsev, AA | 1 |
| Bongiorno, D; Campanile, F; Di Nucci, GD; Pistella, E; Serra, P; Stefani, S; Venditti, M | 1 |
| Cohen, PR; Grossman, ME | 1 |
| Bhaila, I; Ceasar, H; Hamill, RJ; Hulten, K; Lu, MY; Musher, DM; Shelburne, SA | 1 |
| Baker, SD; Horger, DC; Keane, TE | 1 |
| Arnold, FW; Wojda, B | 1 |
| Dushoff, J; Morris, JG; Smith, DL | 1 |
| Chapman, AL; Greig, JM; Innes, JA | 1 |
| Ellis, MW; Lewis, JS | 1 |
| Rumbaugh, JA; Sinha, G; Spalding, C; Speedie, A; Venkatesan, A | 1 |
| Al-Tawfiq, JA; Aldaabil, RA | 1 |
| Kleinschmidt, SL; Munckhof, WJ; Nimmo, GR | 1 |
| Appelbaum, PC | 2 |
| Read, WL | 1 |
| Jeyaratnam, D; Kearns, A; Klein, J; Reid, C | 1 |
| Mahajan, PV; Stankovic, C | 1 |
| Agus, N; Anil, M; Helvaci, M; Ozkalay, N; Sirti, S | 1 |
| Delaney, JA; Dial, S; Schneider, V; Suissa, S | 1 |
| Cunningham, R | 1 |
| Ichimura, W; Isu, K; Kato, N; Osawa, R; Yamane, N; Yanagi, T | 1 |
| Sunakawa, K | 1 |
| Cheng, CK; Lee, TS; Tang, CW | 1 |
| Carleton, HA; Chambers, HF; Graber, CJ; Haller, BL; Perdreau-Remington, F; Wong, MK | 1 |
| Choi, C; Kreye, E; Miller, LG; Sokolov, KM; Tang, AW | 1 |
| Dohin, B; Dumitrescu, O; Etienne, J; Floret, D; Gillet, Y; Lina, G; Vandenesch, F | 1 |
| Acheson, R; Charalampidou, S; Connell, P; Fennell, J; Lynch, M | 1 |
| Adamcova, J; Bartkovjak, M; Benca, J; Deadline, J; Diana, E; Dudasova, T; Johnson, MJ; Juma, O; Kolenova, A; Muli, JM; Namulanda, V; Njambi, Z; Okoth, V; Pauerova, K; Polonova, J; Rabarova, L; Seckova, S; Sladeckova, V; Steno, J; Takacova, M; Taziarova, M | 1 |
| Abughali, N; Hall, GS; Kumar, D; Kumar, ML; Tuohy, M; Yee-Guardino, S | 1 |
| Davis, WR; Pierce, JR; Saeed, Q | 1 |
| Rehm, SJ | 1 |
| Andes, DR; Craig, WA; LaPlante, KL; Leonard, SN; Rybak, MJ | 1 |
| Kollef, MH; Nathwani, D; Rubinstein, E | 1 |
| Heymann, WR; Kil, EH; Weinberg, JM | 1 |
| Bell, B; Cooper, M; Golledge, CL; Riley, TV | 1 |
| Johnston, BL | 1 |
| Cervia, JS; Dunn, AM; Noel, GJ; Stavola, JJ; Tizer, KB | 1 |
| Coque, TM; Murray, BE; Okhyusen, PC; Ricke, SC; Tomayko, JF | 1 |
| Leclercq, R | 1 |
| Bates, J | 1 |
| Buiting, AG; Endtz, HP; Kluytmans, JA; Koeleman, JG; Spanjaard, L; van Belkum, A; van den Braak, N; van Duin, A; Vandenbroucke-Grauls, CM; Verbrugh, HA; Voss, A; Weersink, AJ | 1 |
| Bostic, G; Perri, MB; Silverman, J; Thal, LA; Zervos, MJ | 1 |
| Bullough, K; Cox, D; Neuman, K | 1 |
| Easterbrook, PJ | 1 |
| Bonten, MJ; Hayden, MK; Nathan, C; Slaughter, S; van Voorhis, J; Weinstein, RA | 1 |
| Corey, GR; Fowler, VG; Gottlieb, GS; Harrell, LJ; Kong, LK; Li, J; McClelland, RS; Roussakis, G; Ryan, T; Sanders, LL; Sexton, DJ | 1 |
| Orrett, FA | 1 |
| Roghmann, MC | 1 |
| Feder, HM | 1 |
| Bogdan, MA; Chang, J; Karanas, YL | 1 |
| Alcantara, CS; Guerrant, RL | 1 |
| Gross, PA; Pujat, D | 1 |
| Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM | 1 |
29 review(s) available for vancomycin and Community Acquired Infection
| Article | Year |
|---|---|
Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Daptomycin; Drug Resistance; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2022 |
Vancomycin-resistant Enterococcus faecium pneumonia in a uremic patient on hemodialysis: a case report and review of the literature.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Renal Dialysis; Treatment Outcome; Uremia; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2020 |
A Review on Antistaphylococcal Secondary Metabolites from Basidiomycetes.
Topics: Animals; Anti-Bacterial Agents; Ascomycota; Basidiomycota; Biological Products; Chemistry, Pharmaceutical; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Current and future treatment options for community-associated MRSA infection.
Topics: Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Daptomycin; Doxycycline; Drug Combinations; Humans; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Sulfadoxine; Trimethoprim; Vancomycin | 2018 |
Clostridium difficile Infection in Children.
Topics: Age Factors; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Humans; Incidence; Male; Metronidazole; Prognosis; Risk Assessment; Sex Factors; United States; Vancomycin | 2019 |
Staphylococcus aureus bacteremia, risk factors, complications, and management.
Topics: Age Distribution; Anti-Bacterial Agents; APACHE; Bacteremia; Community-Acquired Infections; Comorbidity; Contraindications; Cross Infection; Female; Humans; Immunocompromised Host; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mortality; Risk Factors; Sex Distribution; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2013 |
Methicillin-resistant Staphylococcus aureus enterocolitis sequentially complicated with septic arthritis: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Bacteremia; Bacterial Typing Techniques; Catheter-Related Infections; Catheters; Clone Cells; Community-Acquired Infections; Cross Infection; Diabetes Mellitus, Type 2; Diagnosis, Differential; Disease Susceptibility; Enterocolitis; Enterocolitis, Pseudomembranous; Equipment Contamination; Evolution, Molecular; Feces; Hip Joint; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Pneumococcal; Shock, Septic; Staphylococcal Infections; Synovial Fluid; Vancomycin | 2014 |
Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Early Diagnosis; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pandemics; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Vancomycin | 2015 |
Case 2: Shoulder Pain in 7-year-old Girl.
Topics: Bacteremia; Child; Combined Modality Therapy; Community-Acquired Infections; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Risk Assessment; Shoulder Pain; Thoracic Surgery, Video-Assisted; Treatment Outcome; Vancomycin | 2016 |
Antimicrobial agents in treatment of MRSA infections.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2008 |
[Community-acquired methicillin-resistant Staphylococcus aureus].
Topics: Adolescent; Anti-Bacterial Agents; Australia; Bacterial Proteins; Bacterial Toxins; Child; Combined Modality Therapy; Community-Acquired Infections; Cross Infection; Debridement; Drainage; Europe; Exotoxins; Genomic Islands; Humans; Leukocidins; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Penicillin-Binding Proteins; Species Specificity; Staphylococcal Infections; United States; Vancomycin; Young Adult | 2008 |
Management of methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Incidence; Infusions, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2010 |
Empyema necessitans and acute osteomyelitis associated with community-acquired methicillin-resistant Staphylococcus aureus in an infant.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Clindamycin; Combined Modality Therapy; Community-Acquired Infections; Drug Therapy, Combination; Empyema, Pleural; Femoral Vein; Femur; Gentamicins; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Popliteal Vein; Radiography; Staphylococcal Infections; Thoracoscopy; Vancomycin; Venous Thrombosis | 2009 |
[Update of antimicrobial resistance in Gram-positive microorganisms].
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterococcus; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; United States; Vancomycin | 2010 |
Update on emerging infections: news from the Centers for Disease Control and Prevention.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Centers for Disease Control and Prevention, U.S.; Community-Acquired Infections; Contraindications; Drug Resistance, Bacterial; Emergency Service, Hospital; Humans; Infection Control; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Practice Guidelines as Topic; Renal Dialysis; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; United States; United States Food and Drug Administration; Vancomycin; Vancomycin Resistance | 2003 |
Antimicrobial resistance among gram-positive organisms in the intensive care unit.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin; Virginiamycin | 2003 |
[Staphylococci and vancomycin--confrontation trends].
Topics: Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Carrier State; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
MRSA--the tip of the iceberg.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Gram-Positive Bacteria; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Community associated MRSA: an alert to paediatricians.
Topics: Anti-Bacterial Agents; Child; Community-Acquired Infections; Drug Therapy, Combination; Genotype; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Soccer; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Staphylococcus aureus: the new adventures of a legendary pathogen.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Cross Infection; Endocarditis; Fasciitis, Necrotizing; Female; Humans; Methicillin Resistance; Middle Aged; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Methicillin-resistant Staphylococcus aureus: an update for the dermatologist, Part 3: Clinical management.
Topics: Acetamides; Algorithms; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Skin Infections; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia--a critical review.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 1994 |
Antibiotic resistance in streptococci and enterococci. Where are we, where are we going? An opening lecture.
Topics: Animals; Cephalosporin Resistance; Community-Acquired Infections; Cross Infection; Disease Reservoirs; Drug Resistance, Multiple; Enterococcus; Gene Transfer Techniques; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Penicillin Resistance; Pneumococcal Infections; Staphylococcus; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1997 |
Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection.
Topics: Animal Feed; Animals; Animals, Domestic; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Microbial; Drug Utilization; Enterococcus; Feces; Glycopeptides; Humans; Vancomycin | 1997 |
Update on Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2000 |
Implementing practice guidelines for appropriate antimicrobial usage: a systematic review.
Topics: Adult; Algorithms; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Female; HIV Infections; Humans; Infant, Newborn; Multicenter Studies as Topic; Otitis Media; Peer Review, Health Care; Pharyngitis; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sinusitis; Surgical Wound Infection; Therapy, Computer-Assisted; Time Factors; Urinary Tract Infections; Vancomycin | 2001 |
5 trial(s) available for vancomycin and Community Acquired Infection
| Article | Year |
|---|---|
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Aztreonam; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Does empiric antibiotic therapy change MRSA [corrected] hand infection outcomes? Cost analysis of a randomized prospective trial in a county hospital.
Topics: Abscess; Adult; Anti-Bacterial Agents; Cefazolin; Community-Acquired Infections; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Hand; Hospital Costs; Hospitals, County; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Soft Tissue Infections; Staphylococcal Infections; Vancomycin | 2014 |
A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2016 |
Should higher vancomycin trough levels be targeted for invasive community-acquired methicillin-resistant Staphylococcus aureus infections in children?
Topics: Anti-Bacterial Agents; Child; Community-Acquired Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2010 |
In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Skin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2010 |
112 other study(ies) available for vancomycin and Community Acquired Infection
| Article | Year |
|---|---|
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cross Infection; Enterococcus; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Respiratory System; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2008 |
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Quebec; Ribotyping; Risk Factors | 2008 |
Improved antimicrobial activity of linezolid against vancomycin-intermediate Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Association of antibiotic use and acute kidney injury in patients hospitalized with community-acquired pneumonia.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Humans; Macrolides; Male; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Vancomycin | 2022 |
Multi-site infection by methicillin-resistant Staphylococcus aureus in a six-year old girl: a case report.
Topics: Anti-Bacterial Agents; Child; Community-Acquired Infections; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2022 |
Invasive pectoral abscess and costal osteomyelitis with bloodstream infection caused by methicillin-resistant Staphylococcus aureus after nasal septoplasty in an immunocompetent adult patient.
Topics: Abscess; Adult; Community-Acquired Infections; Exotoxins; Humans; Leukocidins; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Ribs; Sepsis; Staphylococcal Infections; Vancomycin | 2022 |
Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.
Topics: Agar; Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Furunculosis; Humans; Impetigo; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin | 2022 |
Things We Do For No Reason™: Routine Blood Culture Acquisition for Children Hospitalized with Community-Acquired Pneumonia.
Topics: Amoxicillin; Ampicillin; Blood Culture; Child, Preschool; Community-Acquired Infections; Cough; Dyspnea; Fever; Hospitalization; Humans; Male; Pneumonia; Streptococcus pneumoniae; Vancomycin | 2020 |
Surgical treatment of necrotizing pneumonia in children: a 10-year assessment.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Community-Acquired Infections; Cross-Sectional Studies; Drainage; Female; Humans; Infant; Length of Stay; Male; Medical Records; Oxacillin; Pneumonia, Necrotizing; Postoperative Complications; Retrospective Studies; Statistics, Nonparametric; Time Factors; Treatment Outcome; Vancomycin | 2020 |
Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Community-Acquired Infections; Female; Georgia; Guidelines as Topic; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 2021 |
Empiric Vancomycin Reduction in a Pediatric Intensive Care Unit.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Infections; Community-Acquired Infections; Decision Support Systems, Clinical; Drug Prescriptions; Empirical Research; Humans; Inappropriate Prescribing; Intensive Care Units, Pediatric; Ohio; Quality Improvement; Vancomycin | 2021 |
Epidemiology of Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Child; Community-Acquired Infections; Female; Hospitalization; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Musculoskeletal Diseases; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Treatment Failure; Vancomycin; Vascular Diseases | 2017 |
Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; Community-Acquired Infections; DNA-Binding Proteins; Genotype; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microscopy, Electron; Mutation; Phenotype; Staphylococcal Infections; Treatment Failure; Vancomycin | 2017 |
Characterization of SCCmec and spa types of methicillin-resistant Staphylococcus aureus isolates from health-care and community-acquired infections in Kerman, Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Child; Community-Acquired Infections; Cross Infection; Female; Humans; Infant; Iran; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Penicillin-Binding Proteins; Staphylococcal Infections; Vancomycin; Young Adult | 2017 |
Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Female; Hospital Mortality; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Readmission; Pharmaceutical Services; Pneumonia; Retrospective Studies; Time Factors; Vancomycin; Withholding Treatment; Young Adult | 2018 |
Occult community acquired Klebsiella pneumoniae purulent meningitis in an adult: A case report.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Fatal Outcome; Fever; Headache; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Meropenem; Middle Aged; Shock, Septic; Thienamycins; Vancomycin | 2018 |
Purulent pericarditis secondary to influenza and community-acquired methicillin-resistant Staphylococcus aureus co-infection.
Topics: Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Humans; Influenza B virus; Influenza, Human; Male; Methicillin-Resistant Staphylococcus aureus; Pericarditis; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2018 |
Comparation of vancomycin penetration into cerebrospinal fluid in postoperative intracranial infection and community-acquired meningitis patients.
Topics: Adult; Anti-Bacterial Agents; Central Nervous System Bacterial Infections; Community-Acquired Infections; Female; Humans; Leukocyte Count; Male; Meningitis, Bacterial; Middle Aged; Postoperative Complications; Vancomycin; Young Adult | 2019 |
Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Community-Acquired Infections; Decision Support Systems, Clinical; Drug Resistance, Bacterial; Emergency Service, Hospital; Escherichia coli Infections; Female; Haemophilus Infections; Health Care Costs; Hospitalization; Humans; Interrupted Time Series Analysis; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mortality; Non-Randomized Controlled Trials as Topic; Pneumonia; Pneumonia, Pneumococcal; Pseudomonas Infections; Risk Assessment; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2019 |
High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Community-Acquired Infections; Epidemiological Monitoring; Genotype; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2019 |
Impact of preoperative MRSA screening and decolonization on hospital-acquired MRSA burden.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Chi-Square Distribution; Chlorhexidine; Community-Acquired Infections; Cross Infection; Elective Surgical Procedures; Hospitals, University; Humans; Incidence; Infection Control; Mass Screening; Medication Adherence; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Nasal Mucosa; Orthopedic Procedures; Patient Admission; Prevalence; Program Evaluation; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2013 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
First imported case of skin infection caused by PVL-positive ST30 community-associated methicillin-resistant Staphylococcus aureus clone in a returning Korean traveler from the Philippines.
Topics: Adult; Bacterial Toxins; Carbuncle; Cephalosporins; Community-Acquired Infections; Exotoxins; Female; Humans; Leukocidins; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Philippines; Republic of Korea; Staphylococcal Skin Infections; Travel; Vancomycin | 2013 |
[Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis].
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Communicable Diseases, Emerging; Community-Acquired Infections; Endocarditis, Bacterial; Female; Gastrectomy; Genes, Bacterial; Gentamicins; Humans; Lymphoma, B-Cell, Marginal Zone; Methicillin-Resistant Staphylococcus aureus; Mitral Valve Insufficiency; Multiple Sclerosis; Neoplasms, Second Primary; Ovarian Neoplasms; Postoperative Complications; Rifampin; Staphylococcal Infections; Stomach Neoplasms; Vancomycin | 2013 |
Cardiac tamponade with community-acquired methicillin-resistant Staphylococcus aureus pericarditis.
Topics: Anti-Bacterial Agents; Cardiac Tamponade; Community-Acquired Infections; Diagnosis, Differential; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pericardial Effusion; Pericardiocentesis; Pericarditis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Female; Hospitalization; Hospitals, Teaching; Humans; Kaplan-Meier Estimate; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Romania; Tertiary Care Centers; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Vancomycin-resistant Enterococcus spp isolated from community acquired infections and colonizations in Querétaro City, Mexico.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Mexico; Vancomycin; Vancomycin Resistance | 2014 |
Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chronic Disease; Community-Acquired Infections; Decision Support Techniques; Female; Hospitalization; Humans; Kidney Failure, Chronic; Liver Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Respiratory Tract Infections; Retrospective Studies; Sepsis; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2014 |
Determination of vancomycin trough level in serum and cerebrospinal fluid of patients with acute community-acquired meningitis: a prospective study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Female; Humans; Iran; Male; Meningitis, Bacterial; Middle Aged; Vancomycin; Young Adult | 2014 |
Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Genes, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Prevalence; Staphylococcal Infections; Taiwan; Vancomycin; Vancomycin Resistance | 2014 |
Septic pulmonary and cerebral embolism caused by community-associated methicillin-resistant Staphylococcus aureus in a healthy child.
Topics: Adolescent; Anti-Bacterial Agents; Carbuncle; Community-Acquired Infections; Humans; Intracranial Embolism; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pulmonary Embolism; Rifampin; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
[Skin infection by community-acquired methicillin resistant Staphylococcus aureus with familial transmission].
Topics: Abscess; Adolescent; Adult; Anti-Bacterial Agents; Carrier State; Child; Community-Acquired Infections; Drug Therapy, Combination; Emergencies; Family Health; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Parents; Siblings; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Toxins; Catheter-Related Infections; Clindamycin; Community-Acquired Infections; Cross Infection; Erythromycin; Exfoliatins; Exotoxins; Female; Genotype; Humans; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Superantigens; Taiwan; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans; Israel; Metronidazole; Prospective Studies; Tertiary Care Centers; Vancomycin | 2016 |
Community-Acquired Pneumonia in Adults: Diagnosis and Management.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Doxycycline; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Macrolides; Male; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2016 |
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Community-Acquired Infections; Computer Simulation; Cost-Benefit Analysis; Decision Trees; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; France; Health Care Costs; Humans; Models, Economic; Quality-Adjusted Life Years; Recurrence; Vancomycin | 2017 |
A case of rapidly progressive necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Combined Modality Therapy; Community-Acquired Infections; Fatal Outcome; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Necrosis; Pneumonia, Staphylococcal; Respiration, Artificial; Vancomycin | 2008 |
Puerperal infection of methicillin-resistant Staphylococcus aureus.
Topics: Adult; Community-Acquired Infections; Female; Follow-Up Studies; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pregnancy; Puerperal Infection; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Staphylococcal Infections; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2008 |
Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Cross Infection; Female; Hospitals, Teaching; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; United Kingdom; Vancomycin; Young Adult | 2009 |
Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacteriolysis; Cell Wall; Community-Acquired Infections; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Gene Expression Regulation, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Oxacillin; Rabbits; Staphylococcal Infections; Trans-Activators; Vancomycin | 2009 |
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2009 |
Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model
Topics: Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Methicillin-resistant Staphylococcus aureus sepsis after elective vaginal prolapse surgery.
Topics: Aged; Anti-Bacterial Agents; Community-Acquired Infections; Female; Gynecologic Surgical Procedures; Humans; Methicillin-Resistant Staphylococcus aureus; Postoperative Complications; Staphylococcal Infections; Urine; Uterine Prolapse; Vancomycin | 2010 |
Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Community-Acquired Infections; Female; Hospitals, Pediatric; Humans; Illinois; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Nafcillin; Staphylococcal Infections; Vancomycin | 2009 |
Community-acquired methicillin-resistant Staphylococcus aureus as a cause of rapidly progressing pyelonephritis with pyonephrosis, necessitating emergent nephrectomy.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pyelonephritis; Pyonephrosis; Staphylococcal Infections; Vancomycin | 2009 |
Community-acquired methicillin-resistant Staphylococcus aureus and Lemierre syndrome.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Daptomycin; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
A refractory case of community-acquired pneumonia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Asthma; Community-Acquired Infections; Critical Illness; Drug Resistance, Bacterial; Drug Therapy, Combination; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Oxygen Inhalation Therapy; Pneumonia, Staphylococcal; Radiography, Thoracic; Recurrence; Risk Assessment; Sputum; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a game changer.
Topics: Adolescent; Anti-Bacterial Agents; Arthritis, Infectious; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Musculoskeletal Diseases; Osteomyelitis; Pyomyositis; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2009 |
Bacteremia caused by a highly-resistant Streptococcus pneumoniae serotype 19A circulating in a daycare center.
Topics: Anti-Bacterial Agents; Bacteremia; Carrier State; Child Day Care Centers; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Israel; Pneumococcal Infections; Rifampin; Serotyping; Streptococcus pneumoniae; Vancomycin | 2010 |
Changing etiology of community-acquired bacterial meningitis in adults: a nationwide multicenter study in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Cephalosporins; Cognition Disorders; Community-Acquired Infections; Female; Humans; Male; Meningitis, Bacterial; Middle Aged; Penicillin Resistance; Prevalence; Republic of Korea; Retrospective Studies; Vancomycin; Young Adult | 2010 |
Neonatal community-acquired pneumonia: pathogens and treatment.
Topics: Anti-Bacterial Agents; China; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Sputum; Thienamycins; Vancomycin | 2010 |
What is MRSA?
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2010 |
Haemophilus influenzae type B meningitis in a previously healthy child.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Bacteremia; Cerebrospinal Fluid; Child Day Care Centers; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Emergencies; Empyema, Subdural; Fatal Outcome; Haemophilus influenzae type b; Haemophilus Vaccines; Humans; Immunity, Herd; Immunocompetence; Male; Meningitis, Haemophilus; Vaccination; Vancomycin | 2010 |
[Enterococci resistant to glycopeptides].
Topics: Chromosomes, Bacterial; Community-Acquired Infections; Cross Infection; Dipeptides; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecium; Europe; France; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Vancomycin | 2010 |
Impact of accessory gene regulator (agr) dysfunction on vancomycin pharmacodynamics among Canadian community and health-care associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Canada; Community-Acquired Infections; Cross Infection; Hemolysin Proteins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Trans-Activators; Vancomycin | 2011 |
Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactams; Clindamycin; Community-Acquired Infections; Data Collection; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Vancomycin | 2011 |
Diagnosis and management of community-acquired pneumonia in adults.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Influenza Vaccines; Linezolid; Macrolides; Oxazolidinones; Pneumococcal Vaccines; Pneumonia, Bacterial; Practice Guidelines as Topic; Risk Factors; Treatment Outcome; United States; Vancomycin | 2011 |
Community-associated methicillin-resistant Staphylococcus aureus causing orbital cellulitis in Australian children.
Topics: Adolescent; Anti-Bacterial Agents; Australia; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Incidence; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Orbit; Orbital Cellulitis; Staphylococcal Infections; Vancomycin | 2011 |
Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cell Culture Techniques; Clindamycin; Community-Acquired Infections; Enzyme-Linked Immunosorbent Assay; Exotoxins; Gene Expression Regulation, Bacterial; Humans; Leukocidins; Leukocytes, Mononuclear; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Models, Biological; Oxazolidinones; Real-Time Polymerase Chain Reaction; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virulence Factors | 2012 |
True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Blood Pressure; Body Temperature; Central Venous Catheters; Coagulase; Community-Acquired Infections; Cross Infection; Diagnosis, Differential; Female; Gentian Violet; Hematologic Diseases; Humans; Male; Middle Aged; Phenazines; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Vancomycin | 2012 |
Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Child, Preschool; Clindamycin; Community-Acquired Infections; Consensus; Drug Substitution; Drug Utilization; Evidence-Based Medicine; Female; Guideline Adherence; Hospitals, Pediatric; Humans; Infant; Inservice Training; Kentucky; Length of Stay; Logistic Models; Male; Patient Readmission; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Practice Patterns, Physicians'; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Orbital cellulitis caused by community-associated methicillin-resistant Staphylococcus aureus in a previously healthy neonate.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drainage; Eye; Humans; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Molecular Typing; Orbital Cellulitis; Staphylococcal Infections; Tomography, X-Ray Computed; Vancomycin | 2013 |
Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Cohort Studies; Community-Acquired Infections; Cross Infection; Female; Genotype; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Penicillin-Binding Proteins; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
Early response of ceftaroline fosamic in the treatment of soft-tissue infections.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Community-Acquired Infections; Endpoint Determination; Humans; Pneumonia; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Comorbidity; Empirical Research; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prevalence; Proportional Hazards Models; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
Community-associated methicillin-resistant Staphylococcus aureus necrotizing pneumonia in a healthy neonate.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Empyema; Female; Humans; Infant, Newborn; Lung; Methicillin-Resistant Staphylococcus aureus; Necrosis; Pneumonectomy; Pneumonia, Staphylococcal; Respiratory Syncytial Virus Infections; Vancomycin | 2014 |
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing | 2013 |
ISSSI 10th meeting in Tsukuba, Japan (16-19 October 2002).
Topics: Community-Acquired Infections; Humans; Infection Control; Methicillin Resistance; Staphylococcal Infections; Staphylococcus; Vancomycin | 2003 |
Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus Endocarditis unresponsive to vancomycin therapy with linezolid.
Topics: Acetamides; Bacteremia; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Male; Meningitis, Listeria; Methicillin Resistance; Middle Aged; Oxazolidinones; Risk Assessment; Severity of Illness Index; Staphylococcal Infections; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2004 |
Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Disease Outbreaks; Disease Transmission, Infectious; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Risk Factors; Staphylococcal Skin Infections; Staphylococcus aureus; United States; Vancomycin | 2004 |
In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.
Topics: Community-Acquired Infections; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Kinetics; Methicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2004 |
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess.
Topics: Abscess; Adult; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Community-Acquired Infections; Disease Susceptibility; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hepatitis C; Humans; Male; Methicillin Resistance; Nafcillin; Orchitis; Prostatitis; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Suppuration; Transurethral Resection of Prostate; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Agricultural antibiotics and human health.
Topics: Agriculture; Animal Feed; Animals; Animals, Domestic; Anti-Bacterial Agents; Community-Acquired Infections; Disease Transmission, Infectious; Enterococcus; Food Additives; Glycopeptides; Humans; Public Health; Vancomycin; Vancomycin Resistance; Zoonoses | 2005 |
MRSA in the community.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Community-Acquired Infections; Enterotoxins; Female; Humans; Methicillin Resistance; Risk Factors; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Vancomycin | 2005 |
Pseudomonas aeruginosa infective endocarditis presenting as bacterial meningitis.
Topics: Acyclovir; Ampicillin; Calcification, Physiologic; Cefepime; Cephalosporins; Community-Acquired Infections; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Gentamicins; Humans; Meningitis, Bacterial; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2005 |
Community-acquired MRSA bacteremic necrotizing pneumonia in a patient with scrotal ulceration.
Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Genital Diseases, Male; Humans; Male; Methicillin Resistance; Pneumonia, Bacterial; Risk Factors; Scrotum; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Treatment Outcome; Ulcer; Vancomycin | 2005 |
In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin: does vancomycin resistance occur?
Topics: Australia; Community-Acquired Infections; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin; Vancomycin Resistance | 2006 |
Community-acquired bacterial meningitis.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Humans; Injections, Spinal; Meningitis, Bacterial; Spinal Puncture; Vancomycin | 2006 |
Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections.
Topics: Adolescent; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Humans; Infant; Male; Methicillin Resistance; Microbial Sensitivity Tests; Sacrococcygeal Region; Scalp; Shoulder; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Community-acquired meningitis and sepsis caused by Chryseobacterium meningosepticum in a patient diagnosed with thalassemia major.
Topics: Adolescent; Anti-Bacterial Agents; beta-Thalassemia; Chryseobacterium; Community-Acquired Infections; Flavobacteriaceae Infections; Humans; Male; Meningitis, Bacterial; Sepsis; Vancomycin | 2006 |
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Community-Acquired Infections; Comorbidity; Databases, Factual; Drug Prescriptions; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Risk Factors; United Kingdom; Vancomycin | 2006 |
Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Community-Acquired Infections; Drug Prescriptions; Enterocolitis, Pseudomembranous; Humans; Odds Ratio; Proton Pump Inhibitors; Risk Factors; United Kingdom; Vancomycin | 2006 |
Methicillin-resistant Staphylococcus aureus pyomyositis presenting with cellulitis-like symptoms.
Topics: Aged; Cellulitis; Community-Acquired Infections; Diagnosis, Differential; Female; Humans; Methicillin Resistance; Pyomyositis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
[Appropriate use of anti-MRSA drugs (discussion)].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Dibekacin; Humans; Immunocompromised Host; Linezolid; Methicillin Resistance; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Penicillin G; Vancomycin; Vancomycin Resistance; Vitreous Body | 2007 |
Intermediate vancomycin susceptibility in a community-associated MRSA clone.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Daptomycin; Humans; Lumbar Vertebrae; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Thrombophlebitis; Treatment Outcome; Vancomycin | 2007 |
Postpartum iliopsoas pyomyositis due to community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Female; Humans; Magnetic Resonance Imaging; Methicillin Resistance; Postpartum Period; Psoas Abscess; Pyomyositis; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Treatment Outcome; Trimethoprim; Vancomycin | 2007 |
[Osteoarticular infections with staphylococcus aureus secreting Panton-Valentine leucocidin].
Topics: Abscess; Acute Disease; Anti-Bacterial Agents; Bacterial Toxins; Bone Diseases; Child; Clindamycin; Community-Acquired Infections; Exotoxins; France; Humans; Immunoglobulins, Intravenous; Leukocidins; Methicillin Resistance; Osteomyelitis; Protein Synthesis Inhibitors; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2007 |
Preseptal cellulitis caused by community acquired methicillin resistant Staphylococcus aureus (CAMRSA).
Topics: Acetamides; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Therapy, Combination; Football; Humans; Linezolid; Male; Methicillin Resistance; Ophthalmic Solutions; Orbital Cellulitis; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Meningitis in diabetic patients.
Topics: Anti-Bacterial Agents; Cefotaxime; Cohort Studies; Community-Acquired Infections; Diabetes Complications; Diabetes Mellitus; Humans; Meningitis, Bacterial; Outcome Assessment, Health Care; Risk Factors; Vancomycin | 2007 |
Recognition and treatment of neonatal community-associated MRSA pneumonia and bacteremia.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Community-Acquired Infections; Drug Administration Schedule; Gentamicins; Humans; Infant, Newborn; Methicillin Resistance; Necrosis; Pneumonia, Staphylococcal; Rifampin; Staphylococcus aureus; Twins; Vancomycin | 2008 |
Prostatic abscess due to community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Abscess; Anti-Bacterial Agents; Community-Acquired Infections; Drainage; Humans; Male; Methicillin Resistance; Middle Aged; Prostatic Diseases; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vi
Topics: Acetamides; Animals; Anti-Bacterial Agents; Clindamycin; Colony Count, Microbial; Community-Acquired Infections; Culture Media; Daptomycin; Disease Models, Animal; Doxycycline; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Community-acquired Clostridium difficile-associated diarrhea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Toxins; Child; Child, Preschool; Clostridioides difficile; Community-Acquired Infections; Cytotoxins; Diarrhea; Feces; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 1995 |
Successful combination vancomycin and rifampin therapy in a newborn with community-acquired Flavobacterium meningosepticum neonatal meningitis.
Topics: Community-Acquired Infections; Drug Therapy, Combination; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Rifampin; Vancomycin | 1995 |
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.
Topics: Adolescent; Adult; Animals; Animals, Domestic; Anti-Bacterial Agents; Chickens; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Enterococcus; Feces; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Middle Aged; Texas; Turkeys; Vancomycin | 1996 |
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Carrier State; Community-Acquired Infections; Cross Infection; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Genotype; Gram-Positive Bacterial Infections; Humans; Netherlands; Polymerase Chain Reaction; Vancomycin | 1997 |
Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Carrier State; Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Vancomycin | 1998 |
Transmission of vancomycin-resistant enterococcus among family members: a case study.
Topics: Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus; Family Health; Female; Gastrointestinal Diseases; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin | 1998 |
Superbugs: are we at the threshold of a new Dark Age?
Topics: Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Methicillin Resistance; Vancomycin | 1998 |
External sources of vancomycin-resistant enterococci for intensive care units.
Topics: Anti-Bacterial Agents; Carrier State; Chicago; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Hospitals, Public; Humans; Infection Control; Intensive Care Units; Length of Stay; Prospective Studies; Risk Factors; Vancomycin | 1998 |
Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Community-Acquired Infections; Cross Infection; Echocardiography, Transesophageal; Endocarditis, Bacterial; Follow-Up Studies; Humans; Lactams; Male; Middle Aged; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 1999 |
Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.
Topics: Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Trinidad and Tobago; Vancomycin | 1999 |
Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Community-Acquired Infections; Cross Infection; Female; Humans; Male; Methicillin Resistance; Middle Aged; Predictive Value of Tests; Retrospective Studies; Risk; Severity of Illness Index; Staphylococcal Infections; Survival Analysis; Vancomycin | 2000 |
Methicillin-resistant Staphylococcus aureus infections in 2 pediatric outpatients.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cefazolin; Cephalexin; Cephalosporins; Child; Clindamycin; Community-Acquired Infections; Drainage; Female; Hospitalization; Humans; Infant; Methicillin Resistance; Neck; Staphylococcal Infections; Staphylococcus aureus; Toes; Treatment Failure; Vancomycin | 2000 |
Community acquired methicillin-resistant Staphylococcus aureus hand infections: case reports and clinical implications.
Topics: Adult; Anti-Bacterial Agents; Child; Community-Acquired Infections; Female; Hand Injuries; Humans; Male; Methicillin Resistance; Middle Aged; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Incidence; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Spain; Streptomycin; Vancomycin | 2001 |